Resources and Information

»Glaucoma Watch STAGING

Mar 29 2007

Case Presentation: Laser Imaging Detects Early ON Damage

Bud O'Leary, OD

Optic nerve damage can be detected long before visual field data uncovers the problem. Read the full case, courtesy of Heidelberg Engineering.
read more

discuss

 

»Clinical Guidelines STAGING

Mar 16 2007

Re-Defining Ocular Hypertension

Bud O'Leary, OD

Is one standard deviation above a mean (IOP>21mm) too simplistic a definition of ocular hypertension?
read more

discuss

 

»Glaucoma Watch STAGING

Jan 30 2007

Optic Nerve Head Measurements with the HRT III

Bud O'Leary, OD

African-American and Hispanic populations have been found to be at greater risk for developing glaucoma, yet the original database for derivation of HRT II stereometric parameters consisted of only Caucasians. The new HRT III database has been expanded to include African-Americans and individuals of Indian (Southeast Asian) origin. Further additions of Hispanic and Asian populations are underway.
read more

discuss

 

»Glaucoma Watch STAGING

Dec 22 2006

NGS Residency Award and Lecture

J. James Thimons, OD, FAAO

The National Glaucoma Society is inviting current residents in optometry and ophthalmology to submit a presentation for a 30-minute lecture at the National Glaucoma Symposium to be held July 28-30, 2007 at the Ocean Edge Resort, Cape Cod, MA.
read more

discuss

 

»Industry News STAGING

Dec 20 2006

Alcon's Travatan Z and Systane Use Different Preservatives

J. James Thimons, OD, FAAO

Alcon Laboratories' voluntary recall of SYSTANE free LIQUID GEL Lubricant Eye Drops does not affect other Alcon products such as TRAVATAN Z. <br/>
read more

discuss

 

»Clinical Guidelines STAGING

Dec 11 2006

Beta Blockers in Glaucoma Management

Bud O'Leary, OD

At a recent NGS seminar, the implications of systemic and topical beta blockers were discussed. Useful guidelines and clinical pearls were highlighted.
read more: Full Members Only

 

»Glaucoma Watch STAGING

Nov 02 2006

Case Presentation: Optic Nerve Imaging

Bud O'Leary, OD

A 48-year-old patient with symmetrical optic nerve appearances and equal IOP’s demonstrated only monocular functional loss. Optic nerve imaging was able to localize the defect and permit earlier intervention.
read more

discuss

 

»Industry News STAGING

Sep 26 2006

Alcon's Travatan Z Solution Receives FDA Approval

Bud O'Leary, OD

Alcon, Inc has just announced that the FDA has approved Travatan Z for treatment of glaucoma and ocular hypertensive patients.
read more

replies (2)

 

 

previous    next